Cargando…

Utilizing reclassification to explore characteristics and prognosis of KDIGO(SCr) AKI subgroups: a retrospective analysis of a multicenter prospective cohort study

BACKGROUND: Acute kidney injury (AKI) is widespread in the intensive care unit (ICU) and affects patient prognosis. According to Kidney Disease: Improving Global Outcomes (KDIGO) guidelines, the absolute and relative increases of serum creatinine (Scr) are classified into the same stage. Whether the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Gui-Ying, Qin, Jun-Ping, An, Youzhong, Kang, Yan, Yu, Xiangyou, Zhao, Mingyan, Ma, Xiaochun, Ai, Yuhang, Xu, Yuan, Xi, Xiuming, Qian, Chuanyun, Wu, Dawei, Sun, Renhua, Li, Shusheng, Hu, Zhenjie, Cao, Xiangyuan, Zhou, Fachun, Jiang, Li, Lin, Jiandong, Chen, Erzhen, Qin, Tiehe, He, Zhenyang, Zhu, Jihong, Du, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648037/
https://www.ncbi.nlm.nih.gov/pubmed/34860139
http://dx.doi.org/10.1080/0886022X.2021.1997761
_version_ 1784610718690050048
author Dong, Gui-Ying
Qin, Jun-Ping
An, Youzhong
Kang, Yan
Yu, Xiangyou
Zhao, Mingyan
Ma, Xiaochun
Ai, Yuhang
Xu, Yuan
Xi, Xiuming
Qian, Chuanyun
Wu, Dawei
Sun, Renhua
Li, Shusheng
Hu, Zhenjie
Cao, Xiangyuan
Zhou, Fachun
Jiang, Li
Lin, Jiandong
Chen, Erzhen
Qin, Tiehe
He, Zhenyang
Zhu, Jihong
Du, Bin
author_facet Dong, Gui-Ying
Qin, Jun-Ping
An, Youzhong
Kang, Yan
Yu, Xiangyou
Zhao, Mingyan
Ma, Xiaochun
Ai, Yuhang
Xu, Yuan
Xi, Xiuming
Qian, Chuanyun
Wu, Dawei
Sun, Renhua
Li, Shusheng
Hu, Zhenjie
Cao, Xiangyuan
Zhou, Fachun
Jiang, Li
Lin, Jiandong
Chen, Erzhen
Qin, Tiehe
He, Zhenyang
Zhu, Jihong
Du, Bin
author_sort Dong, Gui-Ying
collection PubMed
description BACKGROUND: Acute kidney injury (AKI) is widespread in the intensive care unit (ICU) and affects patient prognosis. According to Kidney Disease: Improving Global Outcomes (KDIGO) guidelines, the absolute and relative increases of serum creatinine (Scr) are classified into the same stage. Whether the prognosis of the two types of patients is similar in the ICU remains unclear. METHODS: According to the absolute and relative increase of Scr, AKI stage 1 and stage 3 patients were divided into stage 1a and 1b, stage 3a and 3b groups, respectively. Their demographics, laboratory results, clinical characteristics, and outcomes were analyzed retrospectively. RESULTS: Of the 345 eligible cases, we analyzed stage 1 because stage 3a group had only one patient. Using 53 or 61.88 µmol/L as the reference Scr (Scr(ref)), no significant differences were observed in ICU mortality (P(53)=0.076, P(61.88)=0.070) or renal replacement therapy (RRT) ratio, (P(53)=0.356, P(61.88)=0.471) between stage 1a and 1b, but stage 1b had longer ICU length of stay (LOS) than stage 1a (P(53)<0.001, P(61.88)=0.032). In the Kaplan-Meier survival analysis, no differences were observed in ICU mortality between stage 1a and 1b (P(53)=0.378, P(61.88)=0.255). In a multivariate analysis, respiratory failure [HR = 4.462 (95% CI 1.144–17.401), p = 0.031] and vasoactive drug therapy [HR = 4.023 (95% CI 1.584–10.216), p = 0.003] were found to be independently associated with increased risk of death. CONCLUSION: ICU LOS benefit was more prominent in KDIGO(SCr) AKI stage 1a patients than in stage 1 b. Further prospective studies with a larger sample size are necessary to confirm the effectiveness of reclassification.
format Online
Article
Text
id pubmed-8648037
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-86480372021-12-07 Utilizing reclassification to explore characteristics and prognosis of KDIGO(SCr) AKI subgroups: a retrospective analysis of a multicenter prospective cohort study Dong, Gui-Ying Qin, Jun-Ping An, Youzhong Kang, Yan Yu, Xiangyou Zhao, Mingyan Ma, Xiaochun Ai, Yuhang Xu, Yuan Xi, Xiuming Qian, Chuanyun Wu, Dawei Sun, Renhua Li, Shusheng Hu, Zhenjie Cao, Xiangyuan Zhou, Fachun Jiang, Li Lin, Jiandong Chen, Erzhen Qin, Tiehe He, Zhenyang Zhu, Jihong Du, Bin Ren Fail Clinical Study BACKGROUND: Acute kidney injury (AKI) is widespread in the intensive care unit (ICU) and affects patient prognosis. According to Kidney Disease: Improving Global Outcomes (KDIGO) guidelines, the absolute and relative increases of serum creatinine (Scr) are classified into the same stage. Whether the prognosis of the two types of patients is similar in the ICU remains unclear. METHODS: According to the absolute and relative increase of Scr, AKI stage 1 and stage 3 patients were divided into stage 1a and 1b, stage 3a and 3b groups, respectively. Their demographics, laboratory results, clinical characteristics, and outcomes were analyzed retrospectively. RESULTS: Of the 345 eligible cases, we analyzed stage 1 because stage 3a group had only one patient. Using 53 or 61.88 µmol/L as the reference Scr (Scr(ref)), no significant differences were observed in ICU mortality (P(53)=0.076, P(61.88)=0.070) or renal replacement therapy (RRT) ratio, (P(53)=0.356, P(61.88)=0.471) between stage 1a and 1b, but stage 1b had longer ICU length of stay (LOS) than stage 1a (P(53)<0.001, P(61.88)=0.032). In the Kaplan-Meier survival analysis, no differences were observed in ICU mortality between stage 1a and 1b (P(53)=0.378, P(61.88)=0.255). In a multivariate analysis, respiratory failure [HR = 4.462 (95% CI 1.144–17.401), p = 0.031] and vasoactive drug therapy [HR = 4.023 (95% CI 1.584–10.216), p = 0.003] were found to be independently associated with increased risk of death. CONCLUSION: ICU LOS benefit was more prominent in KDIGO(SCr) AKI stage 1a patients than in stage 1 b. Further prospective studies with a larger sample size are necessary to confirm the effectiveness of reclassification. Taylor & Francis 2021-12-03 /pmc/articles/PMC8648037/ /pubmed/34860139 http://dx.doi.org/10.1080/0886022X.2021.1997761 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Dong, Gui-Ying
Qin, Jun-Ping
An, Youzhong
Kang, Yan
Yu, Xiangyou
Zhao, Mingyan
Ma, Xiaochun
Ai, Yuhang
Xu, Yuan
Xi, Xiuming
Qian, Chuanyun
Wu, Dawei
Sun, Renhua
Li, Shusheng
Hu, Zhenjie
Cao, Xiangyuan
Zhou, Fachun
Jiang, Li
Lin, Jiandong
Chen, Erzhen
Qin, Tiehe
He, Zhenyang
Zhu, Jihong
Du, Bin
Utilizing reclassification to explore characteristics and prognosis of KDIGO(SCr) AKI subgroups: a retrospective analysis of a multicenter prospective cohort study
title Utilizing reclassification to explore characteristics and prognosis of KDIGO(SCr) AKI subgroups: a retrospective analysis of a multicenter prospective cohort study
title_full Utilizing reclassification to explore characteristics and prognosis of KDIGO(SCr) AKI subgroups: a retrospective analysis of a multicenter prospective cohort study
title_fullStr Utilizing reclassification to explore characteristics and prognosis of KDIGO(SCr) AKI subgroups: a retrospective analysis of a multicenter prospective cohort study
title_full_unstemmed Utilizing reclassification to explore characteristics and prognosis of KDIGO(SCr) AKI subgroups: a retrospective analysis of a multicenter prospective cohort study
title_short Utilizing reclassification to explore characteristics and prognosis of KDIGO(SCr) AKI subgroups: a retrospective analysis of a multicenter prospective cohort study
title_sort utilizing reclassification to explore characteristics and prognosis of kdigo(scr) aki subgroups: a retrospective analysis of a multicenter prospective cohort study
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648037/
https://www.ncbi.nlm.nih.gov/pubmed/34860139
http://dx.doi.org/10.1080/0886022X.2021.1997761
work_keys_str_mv AT dongguiying utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT qinjunping utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT anyouzhong utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT kangyan utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT yuxiangyou utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT zhaomingyan utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT maxiaochun utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT aiyuhang utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT xuyuan utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT xixiuming utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT qianchuanyun utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT wudawei utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT sunrenhua utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT lishusheng utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT huzhenjie utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT caoxiangyuan utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT zhoufachun utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT jiangli utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT linjiandong utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT chenerzhen utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT qintiehe utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT hezhenyang utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT zhujihong utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy
AT dubin utilizingreclassificationtoexplorecharacteristicsandprognosisofkdigoscrakisubgroupsaretrospectiveanalysisofamulticenterprospectivecohortstudy